Lahti Amanda, Grundberg Anton, Stenman Emelie, Sundquist Kristina
Department of Clinical Sciences Malmö, Center for Primary Health Care Research, Lund University, Malmö, Sweden.
University Clinic Primary Care, Skåne University Hospital, Region Skåne, Sweden.
Eur J Sport Sci. 2025 Jun;25(6):e12325. doi: 10.1002/ejsc.12325.
Ice hockey is a high-intensity sport with high rates of concussions and musculoskeletal injuries. To manage pain, players may (over) use nonsteroid anti-inflammatory drugs (NSAIDs) which can have adverse health effects. In 2022, the Swedish Women's Elite League (SDHL) became the first women's league to introduce body checking, potentially increasing injury risks and NSAID use. This study examines NSAID consumption among SDHL players and its associations with concussions and musculoskeletal injuries. All 224 players registered in SDHL 2023/2024 were invited to participate. The data of 158 included players (71%) aged (mean ± standard deviation) 23.4 ± 4.5 years were analyzed. NSAID use, concussions and musculoskeletal injury rates were assessed through a self-reported questionnaire. In all players, 18% used NSAID at least once weekly, 15% used them one to three times per week, and 3% used them four to seven times per week. Players with previous concussions without persistent symptoms or musculoskeletal injuries did not have significantly higher odds of using more NSAIDs than those without. Players with persistent symptoms after concussion(s) were approximately five times more likely to use NSAIDs weekly than those with previous concussion(s) but without persistent symptoms (Odds Ratio (95% confidence interval): 4.9 (1.1, 21.3)) (p < 0.05). In conclusion, almost one-fifth of female ice hockey players used NSAIDs weekly. Players with persistent post-concussion symptoms are a subgroup that should be monitored more closely to prevent excessive NSAID use. The observed NSAID usage rates presented in this study represent important (baseline) reference values in female ice hockey players allowed to body check.
冰球是一项高强度运动，脑震荡和肌肉骨骼损伤发生率很高。为了缓解疼痛，运动员可能（过度）使用非甾体抗炎药（NSAIDs），而这些药物可能会对健康产生不良影响。2022年，瑞典女子精英联赛（SDHL）成为首个引入身体冲撞的女子联赛，这可能会增加受伤风险和非甾体抗炎药的使用。本研究调查了SDHL球员的非甾体抗炎药消费情况及其与脑震荡和肌肉骨骼损伤的关联。邀请了2023/2024赛季SDHL注册的所有224名球员参与。分析了158名纳入研究的球员（占71%）的数据，其年龄（均值±标准差）为23.4±4.5岁。通过一份自我报告问卷评估非甾体抗炎药的使用情况、脑震荡和肌肉骨骼损伤发生率。在所有球员中，18%的球员每周至少使用一次非甾体抗炎药，15%的球员每周使用一至三次，3%的球员每周使用四至七次。有过无持续症状的脑震荡或肌肉骨骼损伤的球员，使用更多非甾体抗炎药的几率并不比没有这些情况的球员显著更高。有脑震荡后持续症状的球员每周使用非甾体抗炎药的可能性比有过脑震荡但无持续症状的球员高出约五倍（优势比（95%置信区间）：4.9（1.1，21.3））（p<0.05）。总之，近五分之一的女子冰球运动员每周使用非甾体抗炎药。有脑震荡后持续症状的球员是一个应更密切监测以防止非甾体抗炎药过度使用的亚组。本研究中观察到的非甾体抗炎药使用率代表了允许进行身体冲撞的女子冰球运动员的重要（基线）参考值。
